Figure Gallery

Expression Pattern Search Results for runx1

(401 figures with expression from 192 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Anderson et al., 2015	Fig. 1	WT cdh5^bw306/bw306	standard conditions	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
Bonora et al., 2015	Fig. 2	WT + MO4-rad21a	standard conditions	10-13 somites	posterior lateral plate mesoderm
Butko et al., 2015	Fig. 5	WT WT + MO1-gata2b	standard conditions control	Prim-5	ventral wall of dorsal aorta
	Fig. S4	WT WT + MO1-gata2b	standard conditions control	10-13 somites	posterior lateral mesoderm
	Fig. 6	WT WT + MO1-mib1 WT + MO2-wnt16	standard conditions standard conditions control chemical treatment: pharmaceutical	Prim-5	ventral wall of dorsal aorta
	Fig. 7	WT WT + MO5-notch1a WT + MO7-notch1b	standard conditions standard conditions control	Prim-5	ventral wall of dorsal aorta
	Fig. 2	WT	control	Prim-5	ventral wall of dorsal aorta
Cortes et al., 2015	Fig. 4	WT cyp2r1^zf734/zf734	standard conditions	Prim-15	ventral wall of dorsal aorta
	Fig. 3	WT	control chemical treatment by environment: 20-hydroxycholesterol, chemical treatment by environment: calciol chemical treatment by environment: calciol chemical treatment by environment: 20-hydroxycholesterol	Prim-25	ventral wall of dorsal aorta
Deveau et al., 2015	Fig. 4	AB AB + MO4-dnmt1 hsi1Tg; zdf13Tg + MO4-dnmt1	standard conditions heat shock	Prim-25	dorsal aorta hematopoietic stem cell
	Fig. 1	AB hsi1Tg; zdf13Tg	standard conditions heat shock	Prim-25	dorsal aorta hematopoietic stem cell
	Fig. 2	AB hsi1Tg; zdf13Tg + MO1-meis1b	standard conditions heat shock	Prim-5	dorsal aorta hematopoietic stem cell
Esain et al., 2015	Fig. 6	WT WT + MO1-selp WT + MO1-selplg	control chemical treatment: cannabinoid receptor agonist	Prim-25	intermediate cell mass of mesoderm
	Fig. 1	WT WT + MO2-cnr2 WT + MO5-cnr1	standard conditions control chemical treatment: 2-arachidonoylglycerol chemical treatment: anandamide chemical treatment: cannabinoid receptor agonist	Prim-15	ventral wall of dorsal aorta
	Fig. 4	WT WT + MO2-cnr2	control chemical treatment: cannabinoid receptor agonist, chemical treatment: SC560 chemical treatment: cannabinoid receptor agonist, chemical treatment: NS-398 chemical treatment: cannabinoid receptor agonist chemical treatment: SC560 chemical treatment: NS-398	Prim-15	ventral wall of dorsal aorta
	Fig. 2	WT	control chemical treatment: cannabinoid receptor agonist chemical treatment: cannabinoid receptor agonist	Prim-15	intermediate cell mass of mesoderm ventral wall of dorsal aorta
	Fig. 5	WT	control chemical treatment: cannabinoid receptor agonist, chemical treatment: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor chemical treatment: cannabinoid receptor agonist, chemical treatment: NS-398 chemical treatment: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor chemical treatment: cannabinoid receptor agonist chemical treatment: NS-398	Prim-5 to Prim-25	intermediate cell mass of mesoderm ventral wall of dorsal aorta
Gao et al., 2015	Fig. 2	WT topbp1^{cas003/cas003}	control	Prim-25	hematopoietic multipotent progenitor cell
He et al., 2015	Fig. 3	TU TU + MO1-myd88 TU + MO1-nfkbiaa TU + MO1-tlr4bb hkz010tTg hkz010tTg + MO1-myd88 hkz010tTg + MO1-tlr4bb TU + MO1-myd88 + MO1-nfkbiaa TU + MO1-nfkbiaa + MO1-tlr4bb	control standard conditions heat shock	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 2	TU WT myd88^{hu3568/hu3568} TU + MO1-myd88 TU + MO1-nfkbiaa TU + MO1-tlr4bb	standard conditions control chemical treatment: JSH-23	Prim-5 to Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. S3	TU TU + CRISPR1-myd88 + CRISPR2-myd88 + CRISPR3-myd88 + CRISPR4-myd88 + CRISPR5-myd88 TU + CRISPR1-nfkb2 + CRISPR2-nfkb2 + CRISPR3-nfkb2 + CRISPR4-nfkb2 + CRISPR5-nfkb2 TU + CRISPR1-rela + CRISPR2-rela + CRISPR3-rela + CRISPR4-rela + CRISPR5-rela TU + CRISPR1-tlr4bb + CRISPR2-tlr4bb + CRISPR3-tlr4bb + CRISPR4-tlr4bb + CRISPR5-tlr4bb	standard conditions	Prim-5 to Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 5	TU TU + MO2-csf3r TU + MO4-tnfrsf1b TU + MO1-nfkbiaa + MO2-csf3r TU + MO1-nfkbiaa + MO4-tnfrsf1b	standard conditions	Prim-5 to Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. S8	TU TU + MO2-irf8 TU + MO2-spi1b TU + MO3-cebp1	standard conditions	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
Jia et al., 2015	Fig. S5	WT kri1^{cas002/cas002}	standard conditions	Prim-25	ventral wall of dorsal aorta
Jing et al., 2015	Fig. 2	TU TU + MO1-adora2b TU + MO2-adora2b	standard conditions control chemical treatment: BAY 60-6583	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell